Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Form 8.3 - Scapa Group PLC

5 Feb 2021 11:44

RNS Number : 1814O
Maven Investment Partners Ltd
05 February 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

 

(a) Full name of discloser:

Maven Investment Partners Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Scapa Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

04/02/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

66,231

0.04

0

0

(2) Cash-settled derivatives:

 

2,766,095

1.47

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

2,832,326

1.51

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5p ordinary

Sale

1,849

225.5

5p ordinary

Sale

1,288

225.5

5p ordinary

Sale

2,698

225.5

5p ordinary

Sale

1,375

225.5

5p ordinary

Sale

22,790

225.5

5p ordinary

Sale

1,337

228

5p ordinary

Sale

1,750

228

5p ordinary

Sale

2,093

228

5p ordinary

Sale

1,377

228

5p ordinary

Sale

2,183

228

5p ordinary

Sale

1,937

228

5p ordinary

Sale

1,342

228

5p ordinary

Sale

413

228

5p ordinary

Sale

1,153

228

5p ordinary

Sale

390

228

5p ordinary

Sale

1,323

228

5p ordinary

Sale

437

228

5p ordinary

Sale

1,329

227.5

5p ordinary

Sale

1,356

227.5

5p ordinary

Sale

1,750

227.5

5p ordinary

Sale

1,370

227.5

5p ordinary

Sale

3,174

229

5p ordinary

Sale

306

229.5

5p ordinary

Sale

324

229

5p ordinary

Sale

370

229.5

5p ordinary

Sale

472

229.5

5p ordinary

Sale

231

229.5

5p ordinary

Sale

5,000

229

5p ordinary

Sale

1,750

229

5p ordinary

Sale

1,360

229

5p ordinary

Sale

2,639

229

5p ordinary

Sale

1,000

229

5p ordinary

Sale

4,927

229

5p ordinary

Sale

5,417

229

5p ordinary

Sale

1,490

229

5p ordinary

Sale

10,000

229

5p ordinary

Sale

3,166

228.5

5p ordinary

Sale

1,250

228.5

5p ordinary

Sale

424

228.5

5p ordinary

Sale

2,253

228.5

5p ordinary

Sale

2,907

228.5

5p ordinary

Sale

756

229

5p ordinary

Sale

600

229

5p ordinary

Sale

359

229

5p ordinary

Sale

1,343

229

5p ordinary

Sale

1,403

229

5p ordinary

Sale

570

229

5p ordinary

Sale

119

229

5p ordinary

Sale

619

229

5p ordinary

Sale

2,352

229

5p ordinary

Sale

1,387

229

5p ordinary

Sale

1,286

229

5p ordinary

Sale

1,066

229

5p ordinary

Sale

1,281

229

5p ordinary

Sale

1,443

229

5p ordinary

Sale

310

229

5p ordinary

Sale

1,071

229

5p ordinary

Sale

1,555

229

5p ordinary

Sale

1,353

228.5

5p ordinary

Sale

1,496

228.5

5p ordinary

Sale

2,430

228.5

5p ordinary

Sale

1,402

228.5

5p ordinary

Sale

1,303

228.5

5p ordinary

Sale

1,410

228.5

5p ordinary

Sale

1,291

228.5

5p ordinary

Sale

1,061

228.5

5p ordinary

Sale

959

228.5

5p ordinary

Sale

208

228

5p ordinary

Sale

1,646

228

5p ordinary

Sale

332

228

5p ordinary

Sale

1,250

228

5p ordinary

Sale

11

228.5

5p ordinary

Sale

97

228.5

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

05/02/2021

Contact name:

Peter Teng

Telephone number*:

+44 20 3876 8718

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFSLFVIEIIL
Date   Source Headline
19th May 20201:35 pmRNSStandard form for notification of major holdings
14th May 202012:06 pmRNSResults of Placing
14th May 20207:00 amRNSTrading Update, Financing and Proposed Placing
7th May 20207:00 amRNSUpdate on Notice of Full Year Results
4th May 20207:00 amRNSDirectorate Changes
30th Apr 202010:20 amRNSTotal Voting Rights
27th Apr 20203:03 pmRNSHolding(s) in Company
16th Apr 20209:33 amRNSAdditional Listing of Shares
31st Mar 202010:00 amRNSTotal Voting Rights
27th Mar 20207:00 amRNSCOVID-19 UPDATE
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 202010:00 amRNSBlock Listing Application
3rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 20209:41 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSScapa Group Directorate Change
27th Feb 202011:44 amRNSHolding(s) in Company
14th Feb 20209:00 amRNSHolding(s) in Company
12th Feb 202010:00 amRNSHolding(s) in Company
12th Feb 20207:00 amRNSTrading Update
31st Jan 202010:15 amRNSTotal Voting Rights
24th Jan 202010:45 amRNSBlock listing six monthly return
20th Jan 20202:38 pmRNSDirectorate Appointment
2nd Jan 20202:06 pmRNSTotal Voting Rights
29th Nov 201911:08 amRNSTotal Voting Rights
28th Nov 20192:41 pmRNSStandard form for notification of major holdings
22nd Nov 20191:17 pmRNSCorrection - Holding(s) in Company
21st Nov 201910:14 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSScapa Group: Interim Results
12th Nov 20194:16 pmRNSStandard form for notification of major holdings
31st Oct 20199:58 amRNSTotal Voting Rights
25th Oct 20197:00 amRNSNotice of Results
9th Oct 20197:00 amRNSPeriod end update
30th Sep 20199:20 amRNSTotal Voting Rights
13th Sep 201911:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:22 amRNSTotal Voting Rights
7th Aug 20194:29 pmRNSAdditional Listing
31st Jul 20193:29 pmRNSTotal Voting Rights
25th Jul 201910:30 amRNSBlock listing Interim Review
23rd Jul 20194:39 pmRNSResult of AGM
23rd Jul 20197:00 amRNSAGM Statement
11th Jul 20197:00 amRNSScapa commences legal action against ConvaTec
9th Jul 201910:38 amRNSAdditional Listing
2nd Jul 20191:37 pmRNSTotal Voting Rights
28th Jun 20193:36 pmRNSDirectorate Change
21st Jun 20192:05 pmRNSDirector/PDMR Shareholding
19th Jun 201912:49 pmRNSHolding(s) in Company
18th Jun 20198:46 amRNSDirector/PDMR Shareholding
14th Jun 20199:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.